US Patent 11180551 Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
Patent 11180551 was granted and assigned to EyePoint Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11180551 Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
